Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer - Tsuneki, Masayuki; Abe, Makoto; Ichihara, Shin; Kanavati, Fahdi (medRxiv, 2022)
Prostate cancer is often a slowly progressive indolent disease. Unnecessary treatments from overdiagnosis are a significant concern, particularly low-grade disease. Active surveillance has being considered as a risk management strategy to avoid potential side effects by unnecessary radical treatment. In 2016, American Society of Clinical Oncology (ASCO) endorsed the Cancer Care Ontario (CCO) Clinical Practice Guideline on active surveillance for the management of localized prostate cancer. Based on this guideline, we developed a deep learning model to classify prostate adenocarcinoma into indolent (applicable for active surveillance) and aggressive (necessary for definitive therapy) on core needle biopsy whole slide images (WSIs). In this study, we trained deep learning models using a combination of transfer, weakly supervised, and fully supervised learning approaches using a dataset of core needle biopsy WSIs (n=1300). We evaluated the models on a test set (n=645), achieving ROC-AUCs 0.846 (indolent) and 0.980 (aggressive). The results demonstrate the promising potential of deployment in a practical prostate adenocarcinoma histopathological diagnostic workflow system.Competing Interest StatementM.T. and F.K. are employees of Medmain Inc. All authors declare no competing interests.Funding StatementThis study is based on results obtained from a project, JPNP14012, subsidized by the New Energy and Industrial Technology Development Organization (NEDO).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The experimental protocol was approved by the ethical board of Kamachi Group Hospitals (No. 173) and Sapporo-Kosei General Hospital (No. 597). All research activities complied with all relevant ethical regulations and were performed in accordance with relevant guidelines and regulations in the all hospitals mentioned above. Informed consent to use histopathological samples and pathological diagnostic reports for research purposes had previously been obtained from all patients prior to the surgical procedures at all hospitals, and the opportunity for refusal to participate in research had been guaranteed by an opt-out manner.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are not publicly available due to specific institutional requirements governing privacy protection but are available from the corresponding author on reasonable request. The datasets that support the findings of this study are available from Kamachi Group Hospitals (Fukuoka, Japan) and Sapporo-Kosei General Hospital (Sapporo, Japan), but restrictions apply to the availability of these data, which were used under a data use agreement which was made according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects as set by the Japanese Ministry of Health, Labour and Welfare (Tokyo, Japan), and so are not publicly available. However, the data are available from the authors upon reasonable request for private viewing and with permission from the corresponding medical institutions within the terms of the data use agreement and if compliant with the ethical and legal requirements as stipulated by the Japanese Ministry of Health, Labour and Welfare.